Liver Transplantation for Hepatoblastoma: Results from the International Society of Pe+diatric Oncology (SIOP) Study SIOPEL-1 and Review of the World Experience

Pediatric Blood and Cancer

Volumn 42, Issue 1, 2004, Pages 74-83

  Otte, J B ^a   Pritchard, J ^g,h   Aronson, D C ^b   Brown, J ^c   Czauderna, P ^d   Maibach, R ^e   Perilongo, G ^f   Shafford, E ⁱ   Plaschkes, J ^j  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e Intl Breast Cancer Stud Grp   (Switzerland)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

ⁱ ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^j UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

Childhood cancer; Hepatoblastoma; Liver malignancies; Liver transplantation

Indexed keywords

CISPLATIN; DOXORUBICIN; IMMUNOSUPPRESSIVE AGENT;

CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER SURVIVAL; CHILD; CLINICAL PROTOCOL; FEMALE; FOLLOW UP; HEPATOBLASTOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 0842291462     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.10376     Document Type: Review

References (46)

1. Evans AE, Land VJ, Newton WA, et al. Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 1982;50:821-826.
2. Shafford E, Pritchard J. Hepatoblastoma - a bit of a success story? Eur J Cancer 1994;30A:1050-1051.
3. Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of Cisplatin/Vincristine/Fluorouracil and Cisplatin/continuous infusion Doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 2000;18:2665-2675.
4. Von Schweinitz D, Hecker H, Burger D, et al. Surgical therapy of childhood hepatoblastoma. Langenbeckx Archiv für Chirurgie 1995;380:315-320.
5. Von Schweinitz D, Byrd DJ, Hecker H, et al. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. Eur J Cancer 1997;33:1243-1249.
6. Brown J, Perilongo G, Shafford E, et al. Pretreatment prognostic factors for children with hepatoblastoma-results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 2000;36:1418-1425.
7. Pritchard J, Brown J, Shafford E, et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: A successful approach - results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 2000;18:3819-3828.
8. Perilongo G, Shafford E, Plaschkes J. SIOPEL trials using preoperative chemotherapy in hepatoblastoma - A successful approach. Lancet Oncol 2000;1:94-100.
9. Schnater JM, Aronson D, Plaschkes J, et al. Surgical view of the treatment of patients with hepatoblastoma. Results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group (SIOPEL-1). Cancer 2002;94:1111-1120.
10. Ortega JA, Krailo MD, Haas JE, et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: A report from the Children's Cancer Study Group. J Clin Oncol 1991;9:2167-2176.
11. Von Schweinitz D, Hecker H, Harms D, et al. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma - A report from the German Cooperative Pediatric Liver Tumor Study HB-89. J Pediatr Surg 1995;30:845-852.
12. Plaschkes J, Perilongo G, Pritchard J. Pre-operative chemotherapy - Cisplatin (PLA) and doxorubicin (DO) PLADO for the treatment of hepatoblastoma and hepatocellular carcinomas - Results after 2 years' follow-up. Med Pediatr Oncol 1996;27:209.
13. Koneru B, Flye MW, Busuttil RW, et al. Liver transplantation for hepatoblastoma. The American experience. Ann Surg 1991;213:118-121.
14. Douglass EC, Reynolds M, Finegold M, et al. Cisplatin, Vincristine, and Fluorouracil therapy for hepatoblastoma: A Pediatric Oncology Group Study. J Clin Oncol 1993;11:96-99.
15. Chardot C, Saint-Martin C, Gilles A, et al. Living related liver transplantation and vena cava reconstruction after total hepatectomy including vena cava for hepatoblastoma. Transplantation 2001;72:1-3.
16. Stringer MD, Hennayake S, Howard ER, et al. Improved outcome for children with hepatoblastoma. Br J Surg 1995;82:386-391.
17. Reynolds M, Douglass EC, Finegold M, et al. Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg 1992;27:1080-1083.
18. Filler RM, Ehrlich P, Greenberg ML, et al. Preoperative chemotherapy in hepatoblastoma. Surgery 1991;110:591-596.
19. Gururangan S, O'Meara A, MacMahon C, et al. Primary hepatic tumours in children: A 26-year review. J Surg Oncol 1992;50:30-36.
20. Ehrlich P, Greenberg ML, Filler RM. Improved long-term survival with preoperative chemotherapy for hepatoblastoma. J Pediatr Surg 1997;32:999-1003.
21. Carceller A, Blanchard H, Champagne J, et al. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma. J Pediatr Surg 2001;36:755-759.
22. Okada A, Fukuzawa M, Oue T, et al. Thirty-eight years experience of malignant hepatic tumors in infants and childhood. Eur J Pediatr Surg 1998;8:17-22.
23. Seo T, Ando H, Watanabe Y, et al. Treatment of hepatoblastoma: Less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and adriamycin. Surgery 1998;123:407-414.
24. Pimpalwar AP, Sharif K, Ramani P, et al. Strategy for hepatoblastoma management: Transplant vs. non-transplant surgery. J Pediatr Surg 2002;37:240-245.
25. Brugières L, Phillips A, Rondelli R, et al. Hepatoblastoma with microscopic residual disease after surgery: Data from SIOPEL 1 and 2 studies. Med Pediatr Oncol 2000;35:177.
26. Srinivasan P, McCall J, Pritchard J, et al. Orthotopic liver transplantation for unresectable hepatoblastoma. Transplantation 2002;74:652-655.
27. Reyes JD, Carr B, Dvorchik I, et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 2000;136:795-804.
28. Bilik R, Superina R. Transplantation for unresectable liver tumors in children. Transpl Proc 1997;29:2834-2835.
29. Passmore SJ, Noblett HR, Wisheart JD, Mott MG. Prolonged survival following multiple thoracotomies for metastatic hepatoblastoma. Med Pediatr Oncol 1995;24:58-60.
30. Feusner JH, Krailo MD, Haas JE, et al. Treatment of pulmonary metastases of initial stage-1 hepatoblastoma in childhood. Report from the Childrens Cancer Group. Cancer 1993;71:859-864.
31. Perilongo G, Brown J, Shafford E, et al. Hepatoblastoma presenting with lung metastases: Treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors. Cancer 2000;89:1845-1853.
32. Otte JB. Is it right to develop living related liver transplantation? Do reduced and split livers not suffice to cover the needs? Transpl Int 1995;8:69-73.
33. Dower NA, Smith LJ. Liver transplantation for malignant liver tumors in children. Med Pediatr Oncol 2000;34:136-140.
34. Colombani PM, Lau H, Prabhakaran K, et al. Cumulative experience with pediatric living related liver transplantation. J Pediatr Surg 2000;35:9-12.
35. Martinez JA, Rigamonti W, Rahier J, et al. Preserved vascular homograft for revascularization of pediatric liver transplant: A clinical, histological, and bacteriological study. Transplantation 1999;68:672-677.
36. Evrard V, Otte JB, Sokal E, et al. Impact of surgical and immunological parameters in pediatric liver transplantation. Annals of Surgery, in press.
37. Molmenti EP, Wilkinson K, Molmenti H, et al. Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. Am J Transplant 2002;6:535-538.
38. Olthoff KM, Millis M, Rosove MH, et al. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 1990;125:1261-1266.
39. Jenkins RL, Pinson CW, Stone MD. Experience with transplantation in the treatment of liver cancer. Cancer Chemother Pharmacol 1989;23:104-109.
40. Superina R, Billik R. Results of liver transplantation in children with unresectable liver tumors. J Pediatr Surg 1996;31:835-839.
41. Barton JW, Keller MS. Liver transplantation for hepatoblastoma in a child with congenital absence of the portal vein. Pediatr Radiol 1989;20:113-114.
42. Otte JB, Aronson D, Vraux H, et al. Preoperative chemotherapy, major liver resection, and transplantation for primary malignancies in children. Transplant Proc 1996;28:2393-2394.
43. Lockwood L, Heney D, Giles GR, et al. Cisplatin-resistant metastatic hepatoblastoma: Complete response to carboplatin, etoposide, and liver transplantation. Med Pediatr Oncol 1993;21:517-520.
44. Al Qabandi W, Jenkins HC, Buckels JA, et al. Orthotopic liver transplantation for unresectable hepatoblastoma: A single center's experience. J Pediatr Surg 1999;34:1261-1264.
45. Dower NA, Smith LJ, Lees G, et al. Experience with aggressive therapy in three children with unresectable malignant liver tumors. Med Pediatr Oncol 2000;34:132-135.
46. Renz JF, Rosenthal P, Roberts JP, et al. An approach to pediatric liver transplantation for hepatoblastoma. Hepatology 1998;28:737A.